BioTestLab
BioTestLab is a Ukrainian veterinary pharmaceutical manufacturer founded in 1989 that develops and sells 130+ vaccines, antibiotics, antiparasitics, and related animal health products from its GMP- and ISO 9001-certified facilities to livestock, poultry, and companion animal markets across 20 countries via a distributor network.
- Company typePrivate
- Founded1989
- HeadquartersKyiv, Ukraine
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioTestLab does
BioTestLab (БІОТЕСТЛАБ) is a Ukrainian veterinary pharmaceutical company founded in 1989 that develops, manufactures, and sells a broad portfolio of animal health products from its own production facilities in Ukraine. Its catalog spans more than 130 SKUs across live, inactivated, combined, and autogenous vaccines; oral, injectable, powder, and external antibiotics; antiparasitics and coccidiostats; anti-inflammatory, antiseptic, and disinfectant products; vitamin-mineral preparations; immunostimulators; hepatoprotectors; urologicals; sedatives; reproductive and digestive regulators; anesthetics; diagnostic test systems; and detergents. These products target commercial livestock and poultry operations (cattle, pigs, sheep, goats, rabbits, poultry) as well as companion animals (dogs, cats) and horses, with documented brands including TOBRANORM, CIPROX, MAROKS, DORAN, TULAXAN, AMOKSAN PREMIUM, VIROSAN, and BOVIMUN 4.
Manufacturing is performed at company-owned facilities equipped with modern equipment, using SPF embryos and active substances sourced from leading global manufacturers; production is certified to ISO 9001:2015 by DQS (Germany) and aligned with GMP (Good Manufacturing Practice) requirements. The company positions itself as one of the TOP-20 world leaders by vaccine assortment breadth.
BioTestLab's business model is the one-time sale of veterinary pharmaceuticals through a hybrid channel: direct sales from a central office to enterprise agricultural clients in Ukraine (serving 1,500+ client companies), combined with an authorized distributor network that reaches 20 countries. The corporate website is published in six languages (Ukrainian, Russian, English, Spanish, Arabic, French) to support distributor onboarding and international customer acquisition. Pricing is not publicly disclosed, and revenue figures, ownership structure, and management team details are not present in the available source material.
BioTestLab firmographics
Firmographics- Name
- BioTestLab
- Legal name
- BIOTESTLAB LLC
- Website
- https://biotestlab.ua
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- BioTestLab is a Ukrainian veterinary pharmaceutical manufacturer founded in 1989 that develops and sells 130+ vaccines, antibiotics, antiparasitics, and related animal health products from its GMP- and ISO 9001-certified facilities to livestock, poultry, and companion animal markets across 20 countries via a distributor network.
- Ownership category
- akta.pro rank
BioTestLab industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Veterinary Vaccines (Biologics) (HLAMAEAL)
- akta.pro secondary industry
- Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)
Keywords
Where BioTestLab is headquartered
LocationHeadquarters
- HQ city
- Kyiv
- HQ country
- Ukraine
- HQ region
- Europe
Offices1 record
Markets served
BioTestLab business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Pharmaceuticals Sales: Sale of veterinary vaccines, antibiotics, antiparasitics, and other pharmaceutical products for livestock and companion animals
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
BioTestLab product offering
Product offeringCore offering
BioTestLab develops, manufactures, and sells a portfolio of more than 130 veterinary pharmaceutical products — including live, inactivated, combined, and autogenous vaccines; antibiotics; antiparasitics; anti-inflammatory drugs; disinfectants; vitamins; immunostimulators; and diagnostic test systems — for poultry, cattle, swine, sheep, goats, rabbits, dogs, and cats. Production is conducted at the company's own GMP-compliant facilities in Ukraine, certified to ISO 9001:2015 by DQS (Germany), and products are distributed through authorized partners in 20 countries.
Product overview
BioTestLab is a Ukrainian veterinary pharmaceutical company offering a diverse portfolio of over 130 veterinary drug products. The product line includes live, inactivated, combined, and autogenous vaccines for poultry, cattle, pigs, rabbits, sheep, goats, dogs, and cats; antibiotics in oral, powder, injectable, and external forms; antiparasitics; coccidiostats; anti-inflammatory; antiseptic and disinfectant products; vitamin-mineral preparations; immunostimulants; hepatoprotectors; urologicals; sedatives; reproductive cycle regulators; digestive regulators; anesthetics; test systems; and detergents. Specific products include TOBRANORM (tobramycin eye drops), CIPROX (ciprofloxacin eye/ear drops), MAROKS (maropitant injection for antiemetic use), DORAN (doramectin endectocide), TULAXAN (tulathromycin respiratory antibiotic), AMOKSAN PREMIUM (amoxicillin), VIROSAN (disinfectant), and BOVIMUN 4 (cattle vaccine), among many others.
Differentiator
Problem solved
Functional benefit
Products and services
- TOBRANORM (ТОБРАНОРМ) Ophthalmic solution containing tobramycin 3 mg/ml, a fast-acting bactericidal aminoglycoside antibiotic for treating eye infections in dogs and cats.
- CIPROX (ЦИПРОКС) Eye and ear drops containing ciprofloxacin 5 mg/ml, a fluoroquinolone with broad-spectrum antimicrobial properties for treating infectious-inflammatory diseases of eyes and ears in dogs and cats.
- MAROKS (МАРОКС) Injection solution containing maropitant citrate 10 mg/ml, a highly selective NK1 receptor antagonist providing antiemetic action for dogs and cats.
- DORAN (ДОРАН) Injection solution containing doramectin 10 mg/ml, an endectocide with broad-spectrum nematocidal, insecticidal, and acaricidal activity for cattle, sheep, and swine.
- TULAXAN (ТУЛАКСАН) Injection solution containing tulathromycin 100 mg/ml, a semi-synthetic macrolide antibiotic with prolonged action for treating respiratory diseases in cattle, pigs, and sheep.
- AMOKSAN PREMIUM (АМОКСАН ПРЕМІУМ) Antibiotic containing amoxicillin trihydrate 15% for veterinary use across multiple species.
- VIROSAN (ВІРОСАН) Disinfectant containing alkyldimethylbenzylammonium chloride 25% and glutaric aldehyde 11% for facility and equipment sanitation.
- BOVIMUN 4 (БОВІМУН 4) Combined vaccine against respiratory-reproductive complex diseases of cattle.
- Live veterinary vaccines Live attenuated vaccines for poultry, cattle, pigs, rabbits, sheep, and goats covering infectious disease prevention.
- Inactivated veterinary vaccines Inactivated (killed) vaccines for livestock and poultry providing immunity against specific infectious diseases.
- Combined (multi-component) veterinary vaccines Multi-component vaccines providing comprehensive protection against multiple diseases in a single dose for livestock and poultry.
- Autogenous (autologous) veterinary vaccines Custom autogenous vaccines developed for specific farm needs based on isolates from the client's own herd or flock.
- Oral antibiotic solutions Oral antibiotic solutions administered via drinking water or feed for livestock and poultry.
- Powder antibiotic formulations Powder-form antibiotics for in-feed or water medication of livestock and poultry.
- Injectable antibiotic formulations Injectable antibiotic solutions for parenteral administration in livestock and companion animals.
- External (topical) antibiotic formulations Topical antibiotic preparations (ointments, sprays, drops) for external application in animals.
- Antiparasitic veterinary products Endectocides and antiparasitic products for control of internal and external parasites in cattle, swine, sheep, and goats.
- Anticoccidial products (coccidiostats) Coccidiostats for prevention and treatment of coccidiosis in poultry and livestock.
- Anti-inflammatory veterinary products Non-steroidal and steroidal anti-inflammatory drugs for the treatment of inflammation, pain, and fever in animals.
- External antiseptic products Antiseptic preparations applied externally to treat wounds, skin infections, and mucosa in animals.
- Disinfectant and hygiene products Disinfectants and detergents for sanitation of animal housing facilities, equipment, and production areas.
- Vitamin-mineral preparations (feed additives) Vitamin and mineral preparations for supplementation of livestock and poultry diets to support health and productivity.
- Immunostimulant products Immunostimulatory preparations to enhance immune function in animals.
- Hepatoprotector products Hepatoprotective preparations supporting liver function in animals.
- Urological products Urological preparations for the treatment of urinary tract conditions in animals.
- External drops External drops for otic, ophthalmic, or topical use in animals.
- Sedative products Sedative preparations for calming, pre-anesthetic, or handling use in animals.
- Reproductive cycle regulators Hormonal preparations for regulation of the reproductive cycle in livestock.
- Digestive regulators Products for regulation of digestion in livestock and companion animals.
- Anesthetic products Local and general anesthetic preparations for veterinary surgical procedures.
- Veterinary diagnostic test systems Diagnostic test systems for detection of animal diseases and pathogens.
- Detergent products Cleaning detergents for use in animal facilities and veterinary settings.
Quantifiable outcome
- Served 1500+ client companies in Ukraine
Companies that use BioTestLab
Customer profileNamed customers1 record
Segments6 records
Ideal customer profiles2 records
BioTestLab technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BioTestLab partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DQS (Germany)coreDQS is a global leading accreditation agency that certified BioTestLab's quality management system to ISO 9001:2015 standard. This certification demonstrates the company's commitment to international quality standards.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
BioTestLab competitors and assessment
Company assessmentOthers
- IDEXX Laboratories: Global leader in veterinary diagnostics, including in-clinic analyzers, reference laboratory testing, and rapid test kits for companion animals and livestock. BioTestLab's portfolio includes diagnostic test systems, making IDEXX a comparable-but-not-overlapping adjacent player in animal-health diagnostics.
Regional players
- Bioveta: Czech veterinary pharmaceutical company producing vaccines, pharmaceuticals, and diagnostics for livestock and companion animals across Central/Eastern Europe. Comparable in size, product mix, and Eastern European regional positioning to BioTestLab.
Broad incumbents
- Boehringer Ingelheim Animal Health: Top-3 global animal health business within a major human pharma group, producing vaccines and pharmaceuticals across all major livestock and companion species. Overlapping product categories but vastly broader R&D, regulatory, and commercial scale.
- Zoetis: Global leader in animal health and veterinary pharmaceuticals, producing vaccines, anti-infectives, and parasiticides for livestock and companion animals. Directly comparable product portfolio (vaccines + pharmaceuticals) but at vastly greater scale and geographic breadth than BioTestLab.
Direct peers
- Dechra Pharmaceuticals: UK-based veterinary pharmaceutical company focused on companion animal and livestock specialty therapeutics. Comparable product breadth (pharmaceuticals across multiple species) and similar mid-sized positioning.
- Vetoquinol: French independent veterinary pharmaceutical company with a comparable portfolio of vaccines, antibiotics, and anti-inflammatory products for livestock and companion animals. Mid-sized, specialty-focused — directly comparable scale and product breadth to BioTestLab.
- Hipra: Spanish veterinary pharmaceutical company and one of the larger independent vaccine manufacturers for livestock, with strong presence in Europe, Latin America, and MENA. Closely comparable business model: independent veterinary vaccine and pharmaceutical manufacturer with international distribution.
- Virbac: Independent French veterinary pharmaceutical company focused on vaccines, antibiotics, antiparasitics, and specialty products for livestock and companion animals. Closely comparable in product mix (vaccines + pharma + diagnostics-adjacent) and target species.
- Ceva Santé Animale: French multinational veterinary pharmaceutical group producing vaccines, pharmaceuticals, and reproductive products for poultry, swine, and ruminants. Direct competitor in livestock vaccines and pharmaceuticals with strong international distribution.
- Phibro Animal Health: US-listed animal health company specializing in vaccines, anti-infectives, and nutritional specialties for poultry, swine, and cattle. Comparable product mix (vaccines + pharma) and livestock-heavy customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks2 records
Key highlights6 records
Customer concentration
BioTestLab social profiles
Digital presenceBioTestLab compliance and trust
Trust signalCompliance1 record
BioTestLab financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioTestLab leadership team
Management profileNumber of profiles
BioTestLab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioTestLab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioTestLab
What does BioTestLab do?
BioTestLab develops, manufactures, and sells a portfolio of more than 130 veterinary pharmaceutical products — including live, inactivated, combined, and autogenous vaccines; antibiotics; antiparasitics; anti-inflammatory drugs; disinfectants; vitamins; immunostimulators; and diagnostic test systems — for poultry, cattle, swine, sheep, goats, rabbits, dogs, and cats. Production is conducted at the company's own GMP-compliant facilities in Ukraine, certified to ISO 9001:2015 by DQS (Germany), and products are distributed through authorized partners in 20 countries.
Is BioTestLab a public or private company?
BioTestLab is a private company. It is classified as unknown and is currently operating.
When was BioTestLab founded?
BioTestLab was founded in 1989. It employs 101 to 250 people.
Where is BioTestLab based?
BioTestLab is headquartered in Kyiv, Ukraine, in the Europe region.
How does BioTestLab make money?
One revenue line is on record: veterinary Pharmaceuticals Sales.
Who are BioTestLab's main competitors?
IDEXX Laboratories is listed as an others. Bioveta is listed as a regional player. Broad incumbents are Boehringer Ingelheim Animal Health and Zoetis. Direct peers are Dechra Pharmaceuticals, Vetoquinol, Hipra, Virbac, Ceva Santé Animale and Phibro Animal Health.
Does BioTestLab have an API?
No public API is recorded for BioTestLab.
What industry is BioTestLab in?
BioTestLab's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAL, Veterinary Vaccines (Biologics), with a secondary code of AFAEANAK, Veterinary Pharmacy, Vaccine & Biologics Services. Its NAICS code is 325414 and its SIC code is 2836.